University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Ari Green, M.D.

Neurologist

Dr. Ari J. Green is assistant clinical director of the UCSF Multiple Sclerosis (MS) Center and director of the UCSF Neurodiagnostics Center. He treats adults and children with MS and other inflammatory diseases of the central nervous system and has expertise in treating visual problems resulting from these conditions. In his research, he addresses how MS affects the visual system and methods to track and predict the course of the disease. He also uses advanced retinal imaging and electrophysiology to investigate the retina and optic nerve and the relationships between inflammation, demyelination and neurodegeneration in the disease and to better understand injury to nerve fibers of the brain in MS.

Green earned a medical degree at Duke University School of Medicine in Durham, N.C., and completed an internal medicine internship in 2002 and neurology residency in 2005, both at UCSF. In 2005, he was chief resident at UCSF. He completed neuro-immunology and neuro-ophthalmology fellowships at UCSF and has won several awards including a Howard Hughes Medical Institute Early Career Scientist Award and a clinician-scientist award from the National Multiple Sclerosis Society and American Academy of Neurology Foundation. Green is an assistant professor of neurology at UCSF.

Clinics

Multiple Sclerosis Center
1500 Owens St., Suite 320
San Francisco, CA 94158
Phone: (415) 353-2069
Fax: (415) 353-2633

Hours: Monday to Friday
8:30 a.m. – 4:30 p.m.

Conditions & Treatments

More about Ari Green

Education

Duke University Medical School 2001

Residencies

UCSF Medical Center, Neurology 2005

Selected Research and Publications

  1. Green AJ, Schwartz D, Gelfand J. Reply: Microcysts in the inner nuclear layer from optic atrophy are caused by retrograde trans-synaptic degeneration combined with vitreous traction on the retinal surface. Brain. 2013 Nov; 136(Pt 11):e261.
  2. Frohman TC, Beh SC, Saidha S, Schnurman Z, Conger D, Conger A, Ratchford JN, Lopez C, Galetta SL, Calabresi PA, Balcer LJ, Green AJ, Frohman EM. Optic nerve head component responses of the multifocal electroretinogram in MS. Neurology. 2013 Aug 6; 81(6):545-51.
  3. Gelfand JM, Cree BA, Nolan R, Arnow S, Green AJ. Microcystic inner nuclear layer abnormalities and neuromyelitis optica. JAMA Neurol. 2013 May; 70(5):629-33.
  4. Gelfand JM, Green AJ. Reply: Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration. Brain. 2013 Jul; 136(Pt 7):e240.
  5. Green AJ. Getting beyond the ganglion cell: morphometric adjustments for retinal optical coherence tomography in multiple sclerosis. JAMA Neurol. 2013 Jan; 70(1):13-5.
  6. Nolan R, Gelfand JM, Green AJ. Fingolimod treatment in multiple sclerosis leads to increased macular volume. Neurology. 2013 Jan 8; 80(2):139-44.
  7. Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, Ratchford JN, Oh J, Seigo MA, Newsome SD, Balcer LJ, Frohman EM, Green AJ, Nguyen QD, Calabresi PA. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol. 2012 Nov; 11(11):963-72.
  8. Gelfand JM, Goodin DS, Boscardin WJ, Nolan R, Cuneo A, Green AJ. Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. PLoS One. 2012; 7(5):e36847.
  9. Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ. Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. 2012 Jun; 135(Pt 6):1786-93.
  10. Tewarie P, Balk L, Costello F, Green A, Martin R, Schippling S, Petzold A. The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS One. 2012; 7(4):e34823.
  11. Villoslada P, Cuneo A, Gelfand J, Hauser SL, Green A. Color vision is strongly associated with retinal thinning in multiple sclerosis. Mult Scler. 2012 Jul; 18(7):991-9.
  12. Teismann NA, Lenaghan P, Stein J, Green A. Will the real optic nerve sheath please stand up? J Ultrasound Med. 2012 Jan; 31(1):130-1.
  13. Gelfand JM, Cree BA, McElroy J, Oksenberg J, Green R, Mowry EM, Miller JW, Hauser SL, Green AJ. Vitamin D in African Americans with multiple sclerosis. Neurology. 2011 May 24; 76(21):1824-30.
  14. Castillo-Trivino T, Mowry EM, Gajofatto A, Chabas D, Crabtree-Hartman E, Cree BA, Goodin DS, Green AJ, Okuda DT, Pelletier D, Zamvil SS, Vittinghoff E, Waubant E. Switching multiple sclerosis patients with breakthrough disease to second-line therapy. PLoS One. 2011; 6(2):e16664.
  15. Aiken AH, Mukherjee P, Green AJ, Glastonbury CM. MR imaging of optic neuropathy with extended echo-train acquisition fluid-attenuated inversion recovery. AJNR Am J Neuroradiol. 2011 Feb; 32(2):301-5.
  16. Gelfand JM, Duncan JL, Racine CA, Gillum LA, Chin CT, Zhang Y, Zhang Q, Wong LJ, Roorda A, Green AJ. Heterogeneous patterns of tissue injury in NARP syndrome. J Neurol. 2011 Mar; 258(3):440-8.
  17. Green AJ. Optical coherence tomography: a sign of the times. Neurology. 2010 Oct 12; 75(15):1312-3.
  18. Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A, Calabresi PA, Polman C. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2010 Sep; 9(9):921-32.
  19. Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain. 2010 Jun; 133(Pt 6):1591-601.
  20. Green AJ, Cree BA. Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis. J Neurol Neurosurg Psychiatry. 2009 Sep; 80(9):1002-5.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.